Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0275 AUD | +10.00% | -.--% | -.--% |
Feb. 26 | Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Exopharm to Cut CEO Role Amid Cost Reductions | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 3.14M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- EX1 Stock
- News Exopharm Limited
- Exopharm Gets US Patent for Drug Delivery Technology